Mitsubishi UFJ Asset Management Co. Ltd. Buys 12,436 Shares of McKesson Corporation $MCK

Mitsubishi UFJ Asset Management Co. Ltd. grew its stake in shares of McKesson Corporation (NYSE:MCK) by 5.2% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 251,755 shares of the company’s stock after acquiring an additional 12,436 shares during the period. Mitsubishi UFJ Asset Management Co. Ltd.’s holdings in McKesson were worth $194,491,000 at the end of the most recent quarter.

Other large investors also recently made changes to their positions in the company. AlphaCore Capital LLC boosted its stake in McKesson by 36.5% in the 3rd quarter. AlphaCore Capital LLC now owns 2,438 shares of the company’s stock valued at $1,885,000 after purchasing an additional 652 shares during the period. Intech Investment Management LLC increased its position in McKesson by 28.7% during the 3rd quarter. Intech Investment Management LLC now owns 36,750 shares of the company’s stock worth $28,391,000 after buying an additional 8,206 shares during the period. Catalyst Financial Partners LLC lifted its holdings in shares of McKesson by 2.6% during the third quarter. Catalyst Financial Partners LLC now owns 969 shares of the company’s stock worth $749,000 after buying an additional 25 shares in the last quarter. Hager Investment Management Services LLC grew its stake in shares of McKesson by 2.6% in the third quarter. Hager Investment Management Services LLC now owns 1,332 shares of the company’s stock valued at $1,029,000 after acquiring an additional 34 shares in the last quarter. Finally, Empirical Asset Management LLC acquired a new position in shares of McKesson in the third quarter valued at about $205,000. Institutional investors own 85.07% of the company’s stock.

McKesson Price Performance

NYSE MCK opened at $973.59 on Friday. The business has a fifty day moving average price of $865.48 and a two-hundred day moving average price of $803.36. The stock has a market capitalization of $119.26 billion, a PE ratio of 28.00, a PEG ratio of 1.55 and a beta of 0.40. McKesson Corporation has a fifty-two week low of $619.48 and a fifty-two week high of $977.27.

McKesson (NYSE:MCK) last posted its quarterly earnings results on Wednesday, February 4th. The company reported $9.34 EPS for the quarter, topping analysts’ consensus estimates of $9.19 by $0.15. McKesson had a negative return on equity of 338.97% and a net margin of 1.09%.The company had revenue of $106.16 billion during the quarter, compared to analysts’ expectations of $105.98 billion. During the same quarter in the previous year, the firm earned $8.03 EPS. McKesson’s revenue was up 11.4% on a year-over-year basis. McKesson has set its FY 2026 guidance at 38.800-39.200 EPS. As a group, sell-side analysts expect that McKesson Corporation will post 32.77 earnings per share for the current year.

McKesson Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, April 1st. Stockholders of record on Monday, March 2nd will be issued a $0.82 dividend. The ex-dividend date of this dividend is Monday, March 2nd. This represents a $3.28 dividend on an annualized basis and a dividend yield of 0.3%. McKesson’s dividend payout ratio is 9.43%.

Insider Activity at McKesson

In related news, Director Maria Martinez sold 349 shares of the stock in a transaction that occurred on Thursday, February 19th. The shares were sold at an average price of $939.87, for a total value of $328,014.63. Following the completion of the transaction, the director owned 301 shares of the company’s stock, valued at $282,900.87. This represents a 53.69% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CAO Napoleon B. Rutledge, Jr. sold 328 shares of the firm’s stock in a transaction that occurred on Friday, February 6th. The shares were sold at an average price of $955.00, for a total transaction of $313,240.00. The disclosure for this sale is available in the SEC filing. In the last quarter, insiders have sold 1,143 shares of company stock valued at $1,046,070. 0.08% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

A number of research analysts have issued reports on MCK shares. Wall Street Zen lowered shares of McKesson from a “buy” rating to a “hold” rating in a research report on Saturday, November 8th. UBS Group boosted their price target on McKesson from $920.00 to $980.00 and gave the company a “buy” rating in a research note on Thursday, November 6th. Robert W. Baird set a $968.00 price objective on McKesson in a research note on Wednesday, January 14th. Morgan Stanley reiterated an “overweight” rating and set a $966.00 target price on shares of McKesson in a research report on Thursday, January 29th. Finally, Mizuho increased their target price on McKesson from $880.00 to $885.00 and gave the stock a “neutral” rating in a report on Thursday, February 5th. Thirteen analysts have rated the stock with a Buy rating and four have issued a Hold rating to the stock. According to data from MarketBeat, McKesson presently has an average rating of “Moderate Buy” and an average target price of $943.50.

Key Headlines Impacting McKesson

Here are the key news stories impacting McKesson this week:

• Positive Sentiment: Quarterly results showed revenue and operating profit ahead of expectations and management set FY‑2026 EPS guidance (38.80–39.20), reinforcing upward revisions to earnings expectations and investor confidence. A Look At McKesson (MCK) Valuation After Strong Earnings And Growing Analyst Optimism
• Positive Sentiment: Barclays raised its price target to $1,050 (from $960) and kept an Overweight rating, signaling continued analyst support that can attract additional fund buying. Barclays Boosts McKesson (MCK) Price Target, Says Shares Likely to Stay in Favor
• Positive Sentiment: Large institutional inflows have been a key technical driver this year; “big money” accumulation is cited as a reason for the stock’s strong multi‑month run and elevated relative performance. See How Institutional Inflows Make McKesson Fly
• Positive Sentiment: Shares reached an all‑time high, reinforcing momentum and likely triggering additional momentum/quant buying and headline attention. McKesson stock hits all-time high at 972.06 USD
• Neutral Sentiment: Coverage consensus is constructive (e.g., a “Moderate Buy” consensus from brokerages), but valuation metrics (P/E ~28, strong YTD gains) are noted — suggesting upside is supported but the stock could be sensitive to any guidance hiccups or macro shocks. McKesson Corporation (NYSE:MCK) Receives Consensus Rating of “Moderate Buy” from Brokerages

McKesson Profile

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.